Ascend Biopharmaceuticals Limited
Proposed ASX code: ASE
Proposed listing date: Application Withdrawn
|Company contact details||
Ph: 61 3 8606 3488
|Principal Activities||The Company is an Australian biotechnology company that is developing two cancer treatments that utilise a patient?s immune system to recognise and destroy cancers|
|GICS industry group||Not yet allocated|
|Issue Price||35 cents per ordinary share|
|Capital to be Raised||Up to $11,000,000|
|Expected offer close date||31 October 2014|
# Listings dates are proposed dates for first quotation of securities set out in the entity's prospectus or information memorandum. You may not rely on this information in any way.
## Listing dates are anticipated dates for first quotation of securities set by ASX following completion of admission procedures. However, they are subject to change without notice and you may not rely on this information in any way.